These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37671092)

  • 1. TRIM29 knockdown prevented the colon cancer progression through decreasing the ubiquitination levels of KRT5.
    Sun L; Wang D; Chen Z; Zhu X
    Open Life Sci; 2023; 18(1):20220711. PubMed ID: 37671092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E3 ubiquitin ligase TRIM29 promotes pancreatic cancer growth and progression via stabilizing Yes-associated protein 1.
    Deng X; Fu X; Teng H; Fang L; Liang B; Zeng R; Chen L; Zou Y
    J Transl Med; 2021 Aug; 19(1):332. PubMed ID: 34353343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsa_circRNA_0017620 regulated cell progression of non-small-cell lung cancer via miR-520a-5p/KRT5 axis.
    Chen S; Hong K; Zhou L; Ran R; Huang J; Zheng Y; Xing M; Cai Y
    J Clin Lab Anal; 2022 Apr; 36(4):e24347. PubMed ID: 35302673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM29 Reverses Oxaliplatin Resistance of P53 Mutant Colon Cancer Cell.
    Lei G; Liu S; Yang X; He C
    Can J Gastroenterol Hepatol; 2021; 2021():8870907. PubMed ID: 33824865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway.
    Xu J; Li Z; Su Q; Zhao J; Ma J
    Oncol Rep; 2017 Mar; 37(3):1555-1564. PubMed ID: 28098872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non‑coding RNA TP73‑AS1 accelerates the progression and cisplatin resistance of non‑small cell lung cancer by upregulating the expression of TRIM29 via competitively targeting microRNA‑34a‑5p.
    Luo S; Shen M; Chen H; Li W; Chen C
    Mol Med Rep; 2020 Nov; 22(5):3822-3832. PubMed ID: 32901838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing TRIM29 Sensitizes Non-small Cell Lung Cancer Cells to Anlotinib by Promoting Apoptosis
    Wu M; Jin MM; Cao XH; Zhao L; Li YH
    Curr Cancer Drug Targets; 2024; 24(4):445-454. PubMed ID: 37644752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
    Xu R; Hu J; Zhang T; Jiang C; Wang HY
    Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA ELFN1-AS1 upregulates TRIM29 by suppressing miR-211-3p to promote gastric cancer progression.
    Huang J; Yuan W; Chen B; Li G; Chen X
    Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(3):484-497. PubMed ID: 36876422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling.
    Tan ST; Liu SY; Wu B
    Cancer Res Treat; 2016 Oct; 48(4):1302-1312. PubMed ID: 26987391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of tripartite motif (TRIM) 29 inhibits proliferation and invasion and increases chemosensitivity to cisplatin in human lung squamous cancer NCI-H520 cells.
    Liu C; Huang X; Hou S; Hu B; Li H
    Thorac Cancer; 2015 Jan; 6(1):31-7. PubMed ID: 26273332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM29 (Tripartite Motif Containing 29) Alleviates NLRC4 (NLR Family CARD Domain Containing Protein 4) Inflammasome Related Cerebral Injury via Promoting Proteasomal Degradation of NLRC4 in Ischemic Stroke.
    Deng Y; Li Z; Sun X; Ma N; Song L; Chen D; Gao F
    Stroke; 2023 May; 54(5):1377-1389. PubMed ID: 37021569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM29 facilitates the epithelial-to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway.
    Sun J; Zhang T; Cheng M; Hong L; Zhang C; Xie M; Sun P; Fan R; Wang Z; Wang L; Zhong J
    J Exp Clin Cancer Res; 2019 Feb; 38(1):104. PubMed ID: 30813948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM29 facilitates proliferation and malignancy of cholangiocarcinoma cells by activating MAPK and β-catenin pathways.
    Yang J; Bao W; Diao H; Yang S; Qiu L; Xu C; Zhao B
    Environ Toxicol; 2023 Aug; 38(8):2002-2010. PubMed ID: 37219039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-34c-5p mediates the cellular malignant behaviors of oral squamous cell carcinoma through targeted binding of TRIM29.
    Shen Y; Sun C; Zhao B; Guo H; Li J; Xia Y; Liu M; Piao S; Saiyin W
    Ann Transl Med; 2021 Oct; 9(20):1537. PubMed ID: 34790743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM29 mediates lung squamous cell carcinoma cell metastasis by regulating autophagic degradation of E-cadherin.
    Xu W; Chen B; Ke D; Chen X
    Aging (Albany NY); 2020 Jul; 12(13):13488-13501. PubMed ID: 32640423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling.
    Tian J; Yuan L
    Biomed Pharmacother; 2018 Oct; 106():109-116. PubMed ID: 29957460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer.
    Jiang T; Tang HM; Lu S; Yan DW; Yang YX; Peng ZH
    Med Oncol; 2013 Dec; 30(4):715. PubMed ID: 24078150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.